Sign in

    M. Marin

    Senior Analyst at Zacks Investment Research

    M. Marin is a Senior Analyst at Zacks Investment Research specializing in the Technology and Life Sciences sectors, with significant expertise in medical devices, biopharma, and drug development companies. With over 15 years of sell-side research experience, Marin has covered firms in e-commerce, education, real estate, biopharma, med-tech, batteries, electric vehicles, and online gaming, and has been recognized in prominent rankings such as the Wall Street Journal's 'Best on the Street' and Institutional Investor's analyst surveys. Marin began her investment research career at Oppenheimer and Morgan Stanley, later holding senior roles at Salomon Brothers, ING Barings, Bear Stearns, and founding her own digital media-focused research boutique in partnership with Soleil Securities before joining Zacks. She holds a B.A. in economics from Swarthmore College, has completed coursework toward an MBA at New York University, and brings additional experience from investor relations and corporate communications roles.

    M. Marin's questions to CoreCivic (CXW) leadership

    M. Marin's questions to CoreCivic (CXW) leadership • Q2 2025

    Question

    M. Marin of Zacks Investment Research asked for more detail on the competitive advantages of CoreCivic's facilities compared to temporary solutions like 'Alligator Alcatraz.' She also questioned the potential runway for occupancy, noting it had previously been near 87% before the pandemic.

    Answer

    CEO Damon Hininger highlighted that CoreCivic's facilities are more secure, cost-effective, have superior audit scores, and are viewed by ICE as long-term solutions with comprehensive standards, unlike temporary alternatives. CFO David Garfinkle and CEO Damon Hininger confirmed significant runway for occupancy, with Garfinkle suggesting a return to the high-80% range is possible in the short term as ICE is interested in all available capacity.

    Ask Fintool Equity Research AI